
Novel and Emerging Approaches to Melanoma Management: Perspectives for the Community Clinician
Medscape
5.0from 1 ratings
- 4
- Episodes
- 1
- Ratings
- 2022
- First episode
About Novel and Emerging Approaches to Melanoma Management: Perspectives for the Community Clinician
This series of 4 podcasts will include discussions with expert leaders in melanoma. The content will focus on evaluating the use of immune checkpoint inhibitors in Stage II, Stage III, and Stage IV melanoma, understanding and overcoming resistance to anti- programmed cell death protein 1 (PD-1) immunotherapy, advances in the treatment and outcomes of patients with brain metastases, and the use of adjuvant and neoadjuvant treatment approaches.
- Publisher
- Medscape
- Category
- health & fitness · health & fitness
- Language
- en
- Explicit
- No
- First episode
- 19 Aug 2022
- Latest episode
- 23 Sept 2022
Latest episodes
4 episodes in the feed.

23 Sept 2022
Expert Opinion: Use of Adjuvant and Neoadjuvant Approaches in Patients With Stage III Melanoma

14 Sept 2022
Advances in the Treatments and Outcomes for Patients With Melanoma With Brain Metastases

31 Aug 2022
Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma

19 Aug 2022
Evaluating the Use of Immune Checkpoint Inhibitors in Melanoma
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
- Apple Podcasts (US)
- 5.0 / 5
- 1 ratings
Contact Novel and Emerging Approaches to Melanoma Management: Perspectives for the Community Clinician
- Guest appearances
- Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Novel and Emerging Approaches to Melanoma Management: Perspectives for the Community Clinician?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show
Podcast research with Pod Engine